ShareProphets : tidm

INF

Informa (#INF) – “five-month underlying revenue growth of 6.4%… reconfirming full year earnings guidance”

2026-06-18 06:44:48

Informa (#INF) – 2025 adj. EPS +11% to 56p, DPS +10% to 22p, growth outlook for 2026 “trading to plan”

2026-03-12 07:45:19

Informa (#INF) – reaffirms guidance for “double-digit earnings growth in 2025, continuing underlying growth in 2026”

2025-11-11 07:37:40

Informa (#INF) – H1 adj. EPS up to 29.8p, DPS to 7p, “upgraded full year guidance”

2025-07-23 06:42:32

Informa (#INF) – AGM Trading Update, “full year underlying growth guidance reaffirmed”

2025-06-17 06:40:46

Informa (#INF) – 5 months underlying revenue +10.1% YoY, “on track to deliver at the upper end of the 2024 guidance range”

2024-06-21 06:34:58

Informa (#INF) – “delivering at the upper end of guidance range”, increasing share buybacks

2024-05-08 06:24:49

Informa (#INF) – 2023 adj. EPS up to 45.3p, DPS to 18p, “continuing momentum and growth in 2024”

2024-03-08 07:34:58

Shiny Little Squares Remind Me this Outfit could Grow, Along with Its Share Price

Hello Share Pickers. Among my earliest childhood memories, back in the fab ‘fifties, one that stands out is a visit to a trade show dedicated to Formica. I cherished the square inch shiny free samples. Which you must agree is a bit odd. But they do demonstrate the trade exhibition’s peculiar kind of fascination, as those of you who attended Uncle Tom’s legendary share extravaganzas in Westminster will know. A company that today benefits from the special attraction of trade shows is Informa (INF). And it’s doing rather well, even if nobody seems to call them 'trade shows' any more.

By Malcolm Stacey | Published 2023-05-10 07:22:04 |

Outfit that Gives World Companies a Leg Up is Set to Shine as Firms Tussle for a Competitive Edge

Hello, Share Tumblers. I’d started to research a promising company for you, till I discovered it includes making bits for defense. Being a pacifist who strives to respect his enemies rather than kill them, I chose instead to bring before you a firm that deals in supplying information and fostering business contacts.

By Malcolm Stacey | Published 2022-11-16 08:07:30 |

Informa (#INF) – trading performance leads to increase to FY guidance range

2022-11-14 07:54:18

Informa (#INF) – share buyback programme update following Pharma Intelligence business sale agreement

2022-02-16 07:54:16

Informa (#INF) – trading improving FY guidance reiterated, board appointments

2021-11-17 07:33:43

Informa (#INF) – will decide whether to make a debt covenant waiver request in H2 “once there is greater visibility on the performance of the Events businesses”

2020-06-12 07:32:46

Informa (#INF) – extending ‘COVID-19 Action Plan’, including a proposed placing

2020-04-16 07:59:59

Informa (#INF) – 9 month update, progress “on track for full year expectations”

2016-11-07 00:17:09

Informa (#INF) string Q1 trading update - FY forecasts maintained

2015-04-20 23:53:41

previous 0 Page 1 of 1 (17 articles) next 0

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOM18 Sep 2026

a shareholder could call a meeting to propose new directors by PM & pals own 50% of the equity sod vote it down

Letter to Pointon Young, former auditors to Amazing AI

AIMINVESTOR18 Sep 2026

This makes a mockery of the the so called rules and regulations when something as blatant as this is done.It's a shame a shareholder can't propose themselves as a director just to prevent the strike-off.Is there nothing legal that can be done at this point?

Letter to Pointon Young, former auditors to Amazing AI

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast